Evidence map›Paper›PMID 41013716›Full record

ArticleJournal of medical case reports2025

Bilateral eyelid masses and enophthalmos as the initial manifestation of diffuse large B-cell lymphoma: a case report.

Tasnim Ibrahim, Basem Zaino, Maria Bader, Saleem Terkmany, Rabab Salloum

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tasnim IbrahimFaculty of Medicine, Tishreen University, Latakia, Syria. ibrahimtasnim6@gmail.com.ORCID http://orcid.org/0009-0000-0377-5889
Basem ZainoFaculty of Medicine, Tishreen University, Latakia, Syria.ORCID http://orcid.org/0000-0001-5510-709X
Maria BaderFaculty of Medicine, Tishreen University, Latakia, Syria.ORCID http://orcid.org/0009-0006-7654-5658
Saleem TerkmanyNational Hospital, Latakia, Syria.
Rabab SalloumDepartment of Pathology, Tishreen University Hospital, Latakia, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOcular adnexal lymphoma is considered an uncommon disease, but it is among the most common malignancies affecting the ocular adnexa. While diffuse large B-cell lymphoma constitutes 10% of ocular adnexal lymphomas, the initial presentation with bilateral eyelid swelling is quite rare and can be diagnostically challenging. CASE PRESENTATION: Here, we report a case of a 64-year-old Middle Eastern male patient with no prior history of malignancy who presented with a 5-month history of bilateral upper eyelid swelling, mild enophthalmos, and ptosis. The patient had no systemic symptoms. The masses were surgically resected, and histopathological examination confirmed the diagnosis of diffuse large B-cell lymphoma. Following surgical resection, the patient developed submandibular and parotid gland enlargements. Subsequent contrast-enhanced computed tomography scan revealed an enhancing mass posterior to the descending aorta. The patient received six cycles of rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone regimen. Despite the aggressive nature of diffuse large B-cell lymphoma, clinical remission has been achieved. Follow-up positron emission tomography revealed no residual disease.

conclusionBilateral eyelid swelling is a rare initial sign of aggressive lymphoma, such as diffuse large B-cell lymphoma, even in the absence of systemic symptoms. Clinicians should consider malignancy in such atypical presentations to ensure early diagnosis and treatment.

Indexed as

EnophthalmosEyelid NeoplasmsLymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideHumansMaleMiddle AgedPrednisoneRituximabTomography, X-Ray ComputedVincristineCyclophosphamidePrednisoneRituximabVincristineDiffuse large B-cell lymphomaExtranodal lymphomaEyelidOcular adnexaR-CHOP

Identifiers

PMID41013716
PMCPMC12465679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.